Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer Academic Article uri icon

Overview

MeSH Major

  • Algorithms
  • Models, Biological
  • Pharmacokinetics

abstract

  • Circulating tumor cells (CTCs) are cancer cells that can be detected in the blood of prostate cancer patients. We analyzed changes in CTCs after treatment with abiraterone and chemotherapy in two large clinical trials, and found that patients who have a decline in CTC count have a better survival outcome.

publication date

  • December 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5568108

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2016.05.023

PubMed ID

  • 27289566

Additional Document Info

start page

  • 985

end page

  • 992

volume

  • 70

number

  • 6